Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa
Clinical trial NCT06079281 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06079281
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-03
- Primary completion
- 2025-07-09
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.